ICD-10 CM Code P04.1
P04.1
Newborn affected by other maternal medication
-
P04.11 Newborn affected by maternal antineoplastic chemotherapy
-
P04.12 Newborn affected by maternal cytotoxic drugs
-
P04.13 Newborn affected by maternal use of anticonvulsants
-
P04.14 Newborn affected by maternal use of opiates
-
P04.15 Newborn affected by maternal use of antidepressants
-
P04.16 Newborn affected by maternal use of amphetamines
-
P04.17 Newborn affected by maternal use of sedative-hypnotics
-
P04.1A Newborn affected by maternal use of anxiolytics
-
P04.18 Newborn affected by other maternal medication
-
P04.19 Newborn affected by maternal use of unspecified medication
Includes
- nonteratogenic effects of substances transmitted via placenta
Excludes Type 1
- dysmorphism due to warfarin (Q86.2)
- fetal hydantoin syndrome (Q86.1)
Excludes Type 2
- maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0)
- maternal use of drugs of addiction (P04.4-)
- congenital malformations (Q00-Q99)
- encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
- neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
- newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
© ICD10Now.com